PT Central Proteina Prima (CPRO) Fundamentals 2026 — P/E 8.3x, Revenue Analysis | SniperIQ
PT Central Proteina Prima (CPRO) is a ID-listed Consumer Defensive company in Agricultural Farm Products with a market capitalization of Rp3.04T, trading at Rp51.00 on the JKT. This SniperIQ fundamentals page covers PT Central Proteina Prima's valuation (P/E 8.3x, P/B 0.8x), profitability (net margin 3.6%), revenue (Rp9.95T in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is PT Central Proteina Prima's market cap?
PT Central Proteina Prima (CPRO) has a market capitalization of approximately Rp3.04T, trading at Rp51.00 on the JKT. Market cap moves with the live share price.
What is PT Central Proteina Prima's P/E ratio?
PT Central Proteina Prima's trailing twelve-month P/E ratio is 8.3x, with a price-to-book (P/B) of 0.8x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.
How profitable is PT Central Proteina Prima?
PT Central Proteina Prima runs a net profit margin of 3.6%, a gross margin of 19.2%, and an operating margin of 7.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does PT Central Proteina Prima generate?
PT Central Proteina Prima reported revenue of Rp9.95T for fiscal year 2025, with net income of Rp423.7B and earnings per share (EPS) of 7.11. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does PT Central Proteina Prima pay a dividend?
PT Central Proteina Prima does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is PT Central Proteina Prima financially healthy?
PT Central Proteina Prima carries a debt-to-equity ratio of 0.46x and a current ratio of 1.13x, with a market beta of -0.01. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is PT Central Proteina Prima a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PT Central Proteina Prima (CPRO) the key facts are: market cap Rp3.04T, P/E 8.3x, revenue Rp9.95T, 52-week range 50-88. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.
Track PT Central Proteina Prima's full fundamentals live
Get PT Central Proteina Prima's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.